Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
The source supplies the latest action, but no lifecycle stage.
Latest action (22 Jul 2026): Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.
What this bill does
H.R. 6610, the "Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]", would establish new rules for pharmacy benefit managers (PBMs) involved in Federal Employee Health Benefit Plans. These rules would require PBMs to reimburse in-network pharmacies for prescription drugs based on acquisition costs plus a small percentage or fixed fee. They would also mandate that PBMs pay dispensing fees to pharmacies at a rate determined by the state where the pharmacy is located, and pass manufacturer rebates on to federal employees at the point of sale, reducing their out-of-pocket costs. The bill also prohibits PBMs from steering enrollees to specific pharmacies, including their own affiliates, or from implementing practices that exclude or restrict in-network pharmacies.
The bill primarily affects federal employees enrolled in health benefits plans and the pharmacies that serve them, as well as the pharmacy benefit managers that administer prescription drug benefits for these plans. If a PBM violates these new requirements, the Office of Personnel Management could impose civil monetary penalties. The bill also includes provisions for debarment of PBMs after repeated violations and outlines procedures for hearings and appeals. The amendments made by this Act would take effect one year after enactment.
This bill has passed the committee stage and has been ordered reported with amendments. It will next proceed to the full House of Representatives for consideration. If it passes the House, it will then move to the Senate for consideration.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
22 Jul 2026
Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.
Common questions
- What does H.R. 6610 do?
- H.R. 6610, the "Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]", would establish new rules for pharmacy benefit managers (PBMs) involved in Federal Employee Health Benefit Plans. These rules would require PBMs to reimburse in-network pharmacies for prescription drugs based on acquisition costs plus a small percentage or fixed fee. They would also mandate that PBMs pay dispensing fees to pharmacies at a rate determined by the state where the pharmacy is located, and pass manufacturer rebates on to federal employees at the point of sale, reducing their out-of-pocket costs. The bill also prohibits PBMs from steering enrollees to specific pharmacies, including their own affiliates, or from implementing practices that exclude or restrict in-network pharmacies. The bill primarily affects federal employees enrolled in health benefits plans and the pharmacies that serve them, as well as the pharmacy benefit managers that administer prescription drug benefits for these plans. If a PBM violates these new requirements, the Office of Personnel Management could impose civil monetary penalties. The bill also includes provisions for debarment of PBMs after repeated violations and outlines procedures for hearings and appeals. The amendments made by this Act would take effect one year after enactment. This bill has passed the committee stage and has been ordered reported with amendments. It will next proceed to the full House of Representatives for consideration. If it passes the House, it will then move to the Senate for consideration.
- Has H.R. 6610 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 6610. Check the latest action and official source below.
- Who sponsored H.R. 6610?
- H.R. 6610 was sponsored by Rep. Auchincloss, Jake [D-MA-4] (D-MA), with 47 cosponsors.
- What's the latest action on H.R. 6610?
- Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2. (22 Jul 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Auchincloss, Jake [D-MA-4]
CCP Fentanyl Sanctions Act
Alzheimer’s Early Detection Act of 2026
Deepfake Liability Act
Intimate Privacy Protection Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.